Trinity College Dublin researchers collaborating with biotechnology company Exhaura Ltd have developed a gene therapy that has lowered intraocular pressure...
Read moreMuch effort is going into understanding the impact of combined treatments for myopia management, but little is known about the...
Read moreThe coexistence of visual impairment and dementia has been a relatively neglected research topic, but a new Australian study from...
Read moreHow much protein is really deposited on rigid gas permeable (RGP) contact lenses? Scientists at the Centre for Ocular Research...
Read moreEarly anti-VEGF treatment of diabetic retinopathy doesn’t improve visual acuity, according to the results of a four-year clinical study which...
Read moreThe often-cited 20-20-20 rule to avoid digital eye strain may not be an effective therapeutic intervention as previously thought, new...
Read moreFive Australians are among an international team of scientists who have discovered a new gene mutation that may be a...
Read moreScientists have uncovered five genetic variants that increase a person’s risk of developing myopia the longer they stay in school....
Read morePatients with a specific form of age-related macular degeneration (AMD) are also highly likely to have either underlying heart disease,...
Read moreClinical-stage biopharmaceutical company Azura Ophthalmics, which operates out of Melbourne and Tel Aviv, has reported positive three-month results for its...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited